ORIGINAL RESEARCH article
Front. Neurol.
Sec. Multiple Sclerosis and Neuroimmunology
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1568274
This article is part of the Research TopicAdvances in Autoimmune Encephalitis: From Molecular Insights to Therapeutic ApproachesView all articles
Immune Inflammatory Regulation in Anti-NMDAR Encephalitis: Insights from Transcriptome Analysis
Provisionally accepted- 1Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji nan, China
- 2Shandong Provincial Qianfoshan Hospital, Jinan, Shandong Province, China
- 3Qilu Hospital, Shandong University, Jinan, Shandong Province, China
- 4Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a critical neurological disorder mediated by autoimmune mechanisms, Previous literature suggests that immune inflammatory responses may be involved in the progression of anti NMDAR encephalitis, but its molecular regulatory mechanisms still remain uncertain. We aimed to identify transcriptome-wide landscape of mRNAs and explore the potential pathogenesis for anti-NMDAR encephalitis. Methods:Peripheral blood mononuclear cells were obtained from six patients with anti-NMDAR encephalitis and six controls for RNA extraction and library creation. The Illumina HiSeq platform was used to do transcriptome sequencing. We utilized R software to identify differentially expressed genes (DEGs) and performed a functional enrichment analysis. Furthermore, random forest (RF)and support vector machine-recursive feature elimination (SVM-RFE) were employed to to screen for and identify anti-NMDAR encephalitis diagnostic signatures. To verify the findings, we employed quantitative real-time polymerase chain reaction. Receiver operating characteristic curves were utilized to assess the diagnostic values. We evaluated the inflammatory state of anti-NMDAR encephalitis using cell-type identification by computing the relative subsets of RNA transcripts (CIBERSORT) and investigated the relationship between diagnostic biomarkers and immune cell subsets. Results:899 DEGs were identified (568 upregulated and 331 downregulated), of which 78 were immune-related genes. The DEGs were found to be considerably enriched in immunological inflammation-related pathways, according to the functional enrichment analysis. Insulin-like factor 3 (area under the curve [AUC]=0.917) and tumor protein translationally controlled regulator 1 (AUC=0.944) were considered potential diagnostic indicator candidates of anti-NMDAR encephalitis, with statistically significant variations in expression. An immune cell analysis of immune cell proportions suggests that monocytes, CD8+ T cells, and T regulatory cells may all be involved in the development of anti-NMDAR encephalitis. Conclusions: Transcriptome analysis reveals significant activation of peripheral immune-inflammatory pathways in anti-NMDAR encephalitis. INSL3 and TPT1 may serve as potential auxiliary diagnostic biomarkers, while monocyte, CD8+ T cell, and Treg infiltration likely synergistically drive disease progression.
Keywords: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Diagnostic marker, Transcriptomics, Immune Cell Infiltration, Neutrophils
Received: 29 Jan 2025; Accepted: 18 Apr 2025.
Copyright: © 2025 Qiao, Wang, Zhang, Wang, Li and Xin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Shan Qiao, Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Ji nan, China
Haiyun Li, Qilu Hospital, Shandong University, Jinan, 250012, Shandong Province, China
Tao Xin, Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Jinan, 250014, Shandong Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.